Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amedisys (NASDAQ:AMED – Free Report) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, FlyOnTheWall reports. Other research analysts have also issued research reports about the company. Barclays boosted their price target on Amedisys from $88.00 to $101.00 […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Monday morning. The brokerage issued a buy rating on the health services provider’s stock. Other research analysts also recently issued research reports about the stock. SVB Securities reduced their price target on shares of Amedisys from $96.00 […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note issued to investors on Monday morning. The firm issued a buy rating on the health services provider’s stock. AMED has been the topic of several other research reports. Truist Financial increased their price target on shares of Amedisys from $97.00 […]
A number of research firms have changed their ratings and price targets for Amedisys (NASDAQ: AMED): 7/6/2023 – Amedisys was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. 7/3/2023 – Amedisys is now covered by analysts at StockNews.com. They set a “buy” rating on the stock. 6/27/2023 […]
A number of research firms have changed their ratings and price targets for Amedisys (NASDAQ: AMED): 7/6/2023 – Amedisys was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. 7/3/2023 – Amedisys is now covered by analysts at StockNews.com. They set a “buy” rating on the stock. 6/27/2023 […]